Nutrien heads into its third-quarter report with an awkward split personality. The upstream potash business looked sturdier last quarter than at any point in the past year, capital returns are accelerating, and management sounded more confident. Yet the quarter it is about to report is the seasonal trough for fertilizer, and the weakest parts of the portfolio, phosphate and North American retail crop nutrients, tend to show more clearly when big spring volumes are no longer there to cover them.
Wall Street expects earnings of $0.71 a share on revenue of about $5.90 billion when the company reports after the close on November 4. That would be a decline of nearly 24% from the $0.93 earned a year ago on roughly flat sales, which points to margin pressure rather than a collapse in activity. The Earnings Whisper sits lower at $0.63, so the informal bar is below published consensus. That gap matters. It suggests some market participants expect cost inflation, particularly in phosphate inputs, to eat further into profits than analysts' models assume.
The key question is whether the potash momentum from last quarter carried into the second half. Management nudged the bottom of its 2026 potash volume range up to 14.2 to 14.8 million tons, citing strong first-half sales and better visibility, and said Canpotex was fully committed for the third quarter. A committed export book should make offshore volumes the most predictable part of this report. Strong potash tonnage and continued per-ton cost gains, helped by mine automation that already exceeded its 2024 target, would support the idea that the core franchise is improving. Any softness, especially if the company points to El Niño weighing on Southeast Asian demand, would weaken the main reason the tone improved.
Nitrogen is the swing factor that could lift results. Urea prices fell late in the second quarter, but management described firming third-quarter fundamentals from trade disruptions, plant outages and higher energy costs, along with Middle East supply that remains cut off upstream of the Strait of Hormuz. The Carseland turnaround is finished and its debottlenecking added capacity, so nitrogen volumes should compare better than the depressed second quarter. Phosphate is the likely drag. Management called sulfur-driven cost pressure unsustainable and expected second-half demand to stay below historical levels. Further margin deterioration would not surprise anyone, but it would sharpen the focus on the strategic review, where several non-binding bids are being shortlisted. Retail matters too: management reaffirmed $1.75 to $1.95 billion in segment EBITDA by leaning on proprietary products to offset multi-year lows in commodity fertilizer volumes, and fall application trends will show whether that offset is holding.
The mood has cooled even though the stock has done well. Shares are up about 5% since the last report, roughly 5.7 percentage points ahead of the S&P 500, but sentiment has slipped from clearly bullish going into the prior quarter to essentially neutral. The chart reflects the same fading enthusiasm. The stock reached $82.55 after the last report and has since given back most of that gain. At $68.22 it sits in the lower third of its post-earnings range and below its 200-day moving average of $70.89. The market has priced in less optimism than it did a few months ago.
The November 30 Investor Day may cap what management says on this call, but the report should still show whether the second-quarter story holds. If potash volumes and costs stay on track, nitrogen benefits from tighter global supply, and retail meets its reaffirmed range despite weak commodity demand, the step-up in buybacks and the lower capex look sustainable. If phosphate losses widen and retail slips at the same time, the improving narrative will rest almost entirely on potash and a successful phosphate sale.